Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study
Long Chang, Wen-Xin Li, Hao Cai, Jian Li, Ming-Hui Duan
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMyeloproliferative Neoplasms: Diagnosis and Treatment · Eosinophilic Disorders and Syndromes · Chronic Myeloid Leukemia Treatments
In the published article, there was an error in the Funding statement. “The funder National High Level Hospital Clinical Research Funding 2022-PUMCH-B-047 to Ming-hui Duan” was erroneously omitted. The correct Funding statement appears below.
“This study was supported by the National High Level Hospital Clinical Research Funding 2022-PUMCH-B-047 to Ming-hui Duan. This study also received funding from Xiamen Amoytop Biotech Co., Ltd. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.